BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 26968186)

  • 1. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
    Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
    Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
    [No Abstract]   [Full Text] [Related]  

  • 2. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
    Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T
    Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295
    [No Abstract]   [Full Text] [Related]  

  • 3. An 82-year-old woman with left upper lobe atelectasis. Diffuse large B-cell lymphoma.
    Seeram V; Shujaat A; Jones L; Bajwa A
    Chest; 2012 Dec; 142(6):1669-1674. PubMed ID: 23208341
    [No Abstract]   [Full Text] [Related]  

  • 4. Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.
    Huntington SF; Nasta SD; Schuster SJ; Doshi JA; Svoboda J
    Leuk Lymphoma; 2015; 56(9):2579-84. PubMed ID: 25629993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Richter's transformation of chronic lymphocytic leukemia.
    Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
    J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
    Lai S; Venugopal P; Leslie W
    Clin Adv Hematol Oncol; 2012 Feb; 10(2):134-6. PubMed ID: 22402359
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of a primary cardiac B-cell lymphoma.
    Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
    Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
    [No Abstract]   [Full Text] [Related]  

  • 8. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
    Pantelaki I; Tigges C; Nußbaum T; Oellig F; Wieland U; Kreuter A
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508527
    [No Abstract]   [Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma.
    Sengupta S; Benkers T; Blitstein M; Palmer E; Plotkin SR; Abramson JS
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e111-3. PubMed ID: 24581553
    [No Abstract]   [Full Text] [Related]  

  • 11. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
    Mondello P; Cuzzocrea S; Pitini V; Aloisi C; Mian M
    Acta Oncol; 2015 Jun; 54(6):953-5. PubMed ID: 25831143
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma.
    Arakaki H; Nakazato T; Osada Y; Ito C; Aisa Y; Mori T
    Ann Hematol; 2017 Jul; 96(7):1225-1226. PubMed ID: 28508175
    [No Abstract]   [Full Text] [Related]  

  • 13. Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
    Öneç B; Öneç K; Esbah AÜ; Esbah O
    Turk J Haematol; 2016 Dec; 33(4):362-363. PubMed ID: 27095140
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse large B-cell lymphoma resembling a metastatic liver tumour.
    Saitoh Y; Gotoh M; Katagiri S; Ohyashiki K
    Br J Haematol; 2015 Jan; 168(1):1. PubMed ID: 25312576
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
    Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
    Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.
    Stefancikova L; Moulis M; Fabian P; Vasova I; Zedek F; Ravcukova B; Muzik J; Kuglik P; Vranova V; Falkova I; Hrabalkova R; Smardova J
    Int J Oncol; 2011 Dec; 39(6):1413-20. PubMed ID: 21874232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man.
    Montanaro C; Loiacono F; Fragasso G; De Cobelli F; Foppoli M; Margonato A
    Tex Heart Inst J; 2015 Dec; 42(6):561-4. PubMed ID: 26664312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Education and Imaging. Gastroenterology: mesenteric lymphoma with chylous ascites.
    Arasawa S; Nakase H; Minami N
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1570. PubMed ID: 25073631
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A; Gozzetti A; Rigacci L
    Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.